Clinical Trials Logo

ISS Stage I Plasma Cell Myeloma clinical trials

View clinical trials related to ISS Stage I Plasma Cell Myeloma.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03267888 Completed - Clinical trials for Recurrent Plasma Cell Myeloma

Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma

Start date: May 29, 2018
Phase: Phase 1
Study type: Interventional

This pilot clinical trial studies the side effects of pembrolizumab and radiation therapy in treating patients with stage I-III multiple myeloma that has come back after a period of improvement or that does not respond to treatment. Monoclonal antibodies, such as pembrolizumab, may block cancer growth in different ways by targeting certain cells. Radiation therapy uses high energy x-rays to kill cancer cells and shrink tumors. Giving pembrolizumab and radiation therapy may work better in treating patients with stage I-III multiple myeloma.